After reassessing our portfolio positions, we've decided to pivot away from TAO and VRA amid shifting market dynamics. The real opportunity shaping up for 2026 appears to be emerging around alternative plays like REPPO. As the cycle evolves, positioning into potential bluechips becomes critical—sometimes that means recognizing when to rotate out of yesterday's narrative and into fresh developments. Market timing and conviction matter just as much as token selection in this space.